DNN stratifies kidney cancer survival using ten cuproptosis-related genes
Source check: Source checked. Not independent scientific confirmation.
Finding: A deep neural network trained on ten cuproptosis-related gene-expression features stratified kidney clear-cell cancer survival in TCGA and was evaluated in an external ICGC dataset. The authors report AUCs of 0.739 in training and 0.707 in validation. This was retrospective database analysis; proposed drug-target interactions remain computational predictions and clinical benefit was not tested.
Technology: Deep neural network
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- A three-hidden-layer DNN trained on ten cuproptosis-related expression features in TCGA predicts KIRC survival with external ICGC evaluation.
- Test and result
- Retrospective TCGA survival modeling and external ICGC evaluation.
- Limitation / still unknown
- Prospective performance, clinical benefit and predicted drug-target mechanisms were not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC10807644/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Primary full paper Methods, Results and limitations plus Europe PMC bibliographic metadata;reviewed 2026-11-21..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.